His work also suggests that therapies designed to
block immune checkpoints, such as anti-PD-1 antibodies, may act in part by shifting this metabolic competition back in favor of immune cells.
Not exact matches
By administering a complementary antibody, they
blocked the function of two such
immune checkpoints, whereby different types of endogenous T - cells were activated.
Checkpoint inhibitors
block that handshake, which alerts
immune cells to cancer cells and target them for destruction.
Since Allison hatched the idea of
blocking CTLA - 4, several more
immune checkpoints have been identified.
However,
immune cells may be
blocked by inhibitory molecules, which serve as
checkpoints to alleviate or «turn off» the
immune system response, Gu explained.
Allison pioneered
immune checkpoint blockade, an approach that treats the
immune system, rather than the tumor directly, by
blocking molecules on T cells that shut those attack cells down, protecting tumors from
immune response.
Conversely, the
immune system contains triggers to blunt
immune responses, and antibodies that
block these «off - switch»
checkpoints might be able to further reduce the ability of these cancers to escape the
immune system.
Patients in the study were treated with
immune checkpoint inhibitors that
block the activation of PD1, a protein on
immune system T cells that halts
immune response.
A new class of drugs called
immune checkpoint inhibitors
block molecules on T cells that shut down
immune response, freeing the
immune system to attack tumors.
Researchers led by Van Allen and Choueiri sought an explanation for why some patients with a form of metastatic kidney cancer called clear cell renal cell cancer (ccRCC) gain clinical benefit — sometimes durable — from treatment with
immune checkpoint inhibitors that
block the PD - 1
checkpoint, while other patients don't.
Checkpoint blockade: Fewer but stronger results Allison pioneered immune checkpoint blockade, an approach that treats the immune system, rather than the tumor directly, by blocking molecules on T cells that shut those attack cells down, protecting tumors from immune
Checkpoint blockade: Fewer but stronger results Allison pioneered
immune checkpoint blockade, an approach that treats the immune system, rather than the tumor directly, by blocking molecules on T cells that shut those attack cells down, protecting tumors from immune
checkpoint blockade, an approach that treats the
immune system, rather than the tumor directly, by
blocking molecules on T cells that shut those attack cells down, protecting tumors from
immune response.
R&D Systems offers a wide range of reagents and kits designed to study the
immune checkpoint, including
blocking antibodies, proteins, assays, and more.
By
blocking these inhibitory molecules or, alternatively, activating stimulatory molecules,
checkpoint inhibitors are designed to unleash or enhance pre-existing anti-cancer
immune responses.